Discussion Aside from the top 10% of responders in our real-world study, we found that GLP-1s resulted in smaller reductions in both weight loss and HbA1c, respectively
But these changes are expected, and theyre biologically driven. Sustaining progress If youre anxious about stopping a GLP-1, ask your doctor if tapering off gradually, taking a lower dose, or using the drug intermittently is a better option (if thats financially possible), Salamon says
PEG ratios below 1 are generally considered undervalued, so 0.4 is very low
10.1038/nn.4030 Nat Neurosci
Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents
While injectable forms of weight-loss drugs remain the gold standard for efficacy, according to trial results, both Eli Lilly and Novo Nordisk have leaned into pill formulations